Results

Total Results: 1,243 records

Showing results for "topical treatment".

1. Final Progress Report: Topical Vancomycin for Neurosurgery Wound Prophylaxis (pdf file)
   www.ahrq.gov/sites/default/files/2024-03/connolly-report.pdf
   January 01, 2024 - Final Progress Report: Topical Vancomycin for Neurosurgery Wound Prophylaxis Title: Topical Vancomycin … Results: The topical vancomycin treatment group comprised 484 patients (973 total enrolled patients), … vancomycin treatment is safe in the setting of neurological surgery. … For all patients randomized to the treatment group, 1 g of commercially available topical vancomycin … We conclude that topical vancomycin treatment is safe in the setting of neurological surgery.

2. Acute Sinusitis (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/sinusitis-one-pager.pdf
   September 01, 2022 - least 3-4 days of temperatures ≥ 102°F and purulent nasal discharge or facial pain • First-line therapy … Symptomatic Therapy • Analgesic/antipyretic for facial pain and fever • Decongestants (limited to … years of age)32,7 ‒ Oxymetazoline nasal spray or pseudoephedrine orally (may be less effective than topical … )  Topical decongestants should not be used more than 3 to 5 consecutive days due to risk of rebound … Evidence and evidence gaps in therapies of nasal obstruction and rhinosinusitis.

3. References | Agency for Healthcare Research and Quality
   www.ahrq.gov/hai/universal-icu-decolonization/universal-icu-refs.html
   September 01, 2013 - nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment … Mupirocin—A novel topical antibiotic. London: Royal Society of Medicine, 1984: 13-22. 35. … Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections–an … Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections … Topical antimicrobials in combination with admission screening and barrier precautions to control endemic

4. References | Agency for Healthcare Research and Quality
   www.ahrq.gov/es/hai/universal-icu-decolonization/universal-icu-refs.html
   September 01, 2013 - nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment … Mupirocin—A novel topical antibiotic. London: Royal Society of Medicine, 1984: 13-22. 35. … Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections–an … Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections … Topical antimicrobials in combination with admission screening and barrier precautions to control endemic

5. AHRQ Safety Program for MRSA Prevention: Targeting SSI
   www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/004-ss-antimicrobial-prophylaxis-part-2.pptx
   April 01, 2025 - One day versus seven days of preventive antibiotic therapy in orthopedic surgery. … One day versus seven days of preventive antibiotic therapy in orthopedic surgery. … Is topical vancomycin an option? … are rare and emphasize importance of thorough allergy screening Anaphylaxis to cefazolin Alternative treatment … One day versus seven days of preventive antibiotic therapy in orthopedic surgery.

6. Toolkit Prelaunch Activities (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/hai/abate/introduction/prelaunch-activities.pdf
   March 01, 2022 - approval by relevant committees, which may include infection prevention, nursing governance, pharmacy & therapeutics … Prior to launching targeted decolonization, ensure that all stocked prophylactic topical skin products … Topical prescription products prescribed for treatment do not need to be checked as they are required …  Medicated or wound care skin products If your patient is prescribed a treatment regimen for the … Such products can include steroid creams, antifungal creams, and burn or wound creams for treatment

7. Supplemental Document No. 1 (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc1.pdf
   September 01, 2014 - MeSH Terms by CHIPRA Core Measure Topical Areas of Interest CHIPRA Measure Topical Area Maternal … (asthma)  Therapeutic use (asthma)  Primary health care Followup for Children Prescribed … and control (ADHD)  Rehabilitation (ADHD)  Therapy (ADHD) HbA1c Testing for Children with … sufficient evidence that directly addresses the review’s focus; however, prior to 2008, the Multimodal Treatment … Study of ADHD provided evidence that high-quality medication treatment (including monthly followup

8. Appendix E. Training and Educational Materials (continued) | Agency for Healthcare Research and Quality
   www.ahrq.gov/hai/universal-icu-decolonization/universal-icu-ape4.html
   September 01, 2013 - Safety and Adverse Events Protocol Training, Part 1: Mupirocin Background 2% Topical … Topical wound treatment. Nasal ointment is not systemically absorbed. … Protocol Training, Part 2: Chlorhexidine (CHG) Background Topical cleansing agent, over the counter

9. Appendix E. Training and Educational Materials (continued) | Agency for Healthcare Research and Quality
   www.ahrq.gov/es/hai/universal-icu-decolonization/universal-icu-ape4.html
   September 01, 2013 - Safety and Adverse Events Protocol Training, Part 1: Mupirocin Background 2% Topical … Topical wound treatment. Nasal ointment is not systemically absorbed. … Protocol Training, Part 2: Chlorhexidine (CHG) Background Topical cleansing agent, over the counter

10. Scientific Rationale | Agency for Healthcare Research and Quality
    www.ahrq.gov/hai/universal-icu-decolonization/universal-icu-rationale.html
    September 01, 2013 - Mupirocin is a prescription drug that was approved by the Food and Drug Administration (FDA) in 2002 for topical … treatment of mild wounds due to S. aureus and Streptococcus pyogenes . … extensive safety record. 39-44 Several groups have confirmed the absence of systemic absorption following topical

11. Scientific Rationale | Agency for Healthcare Research and Quality
    www.ahrq.gov/es/hai/universal-icu-decolonization/universal-icu-rationale.html
    September 01, 2013 - Mupirocin is a prescription drug that was approved by the Food and Drug Administration (FDA) in 2002 for topical … treatment of mild wounds due to S. aureus and Streptococcus pyogenes . … extensive safety record. 39-44 Several groups have confirmed the absence of systemic absorption following topical

12. Scientific Rationale (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/hai/abate/introduction/scientific-rationale.pdf
    March 01, 2022 - chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment … Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk … Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections … Journal of Dermatological Treatment 1989;(I):83-6. 79. Pappa KA. … Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin

13. Community Connections: Linking Primary Care Patients to Local Resources for Better Management of Obesity | Agency for Healthcare Research and Quality
    www.ahrq.gov/ncepcr/tools/obesity-kit/obtoolkit-tool17.html
    March 01, 2014 - Podiatrist (foot doctor) Dentist Neurologist (specialist for nerve damage) Prediabetes treatment … costs for specialized footwear Average pair diabetes shoes $130 Average pair diabetes socks $10 Topical … foot treatment $10 Physical Activity gear New walking/exercise shoes New workout clothes

14. Table 28. Logistic regression of characteristics associated with utilization of education and case management visits by adults with diabetes or cardiovascular disease. | Agency for Healthcare Research and Quality
    www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chap6tab28.html
    December 01, 2017 - Topical Papers and Briefs Presentations, topical papers and briefs on advanced methods, critical areas

15. 057-Patient-Instructions-Mupirocin (doc file)
    www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/057-patient-instructions-mupirocin.docx
    April 01, 2025 - Mupirocin is a topical antibiotic ointment. … It is not a substitute for your doctor's medical advice and should not be relied upon for treatment for

16. Self-Assessment Worksheet for Pressure Ulcer Healing | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/pruhealing/saworksheet.html
    December 01, 2017 - , European Pressure Ulcer Advisory Panel, and Pan Pacific Pressure Injury Alliance’s Prevention and Treatment … ___ ___   Appropriate use of topical wound agents? … ___ ___   Appropriate use of adjunctive treatments? … specialized footware) ___ Friction and sheer reduction ___ Turning and repositioning procedures ___ Treatment

17. Toolkit for Decolonization of Non-ICU Patients With Devices_Toolkit Overview and Recommended Prelaunch Activities (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/hai/abate/introduction/intro-overview.pdf
    March 01, 2022 - Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk … Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections … and are not used to treat active infection, resistance to these agents will not result in the loss of therapeutic … approval by relevant committees, which may include infection prevention, nursing governance, pharmacy & therapeutics … Topical prescription products prescribed for treatment do not need to be checked as they are required

18. On-Time Pressure Ulcer Healing: Facilitator Training | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/pruhealing/slides.html
    December 01, 2017 - Treatments. Adjunctive therapies. Interventions and consultations. … Ulcer status, number of treatments. … and interventions : Treatments (e.g., wound cleanser, debridement, topical and protective agents … Saline Saline Debridement Autolytic Autolytic Conservative sharp         Topical … Treatments. Surfaces. Nutritional Interventions. Consults. Labs.

19. Delivery System Research Initiative | Agency for Healthcare Research and Quality
    www.ahrq.gov/practiceimprovement/delivery-initiative/index.html
    December 01, 2020 - Topical Papers and Briefs Presentations, topical papers and briefs on advanced methods, critical areas

20. Saworksheet (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/pruhealing/saworksheet.pdf
    June 02, 2025 - European Pressure Ulcer Advisory Panel, and Pan Pacific Pressure Injury Alliance’s Prevention and Treatment … Appropriate use of topical wound agents? Appropriate use of adjunctive treatments? … specialized footware)  Friction and sheer reduction  Turning and repositioning procedures  Treatment